Redondo Beach, CA – November 9, 2001 – The Food & Drug Administration (FDA) has just recently cleared Quantimetrix Corporation’s new Lipoprint System, the only test that measures how much cholesterol is in each LDL (bad) sub-fraction. This new test gives physicians more specific data about a patients LDL sub-fractions […]

Area biotech firm passes FDA test After 10 years of development, Quantimetrix Corp. of Redondo Beach has won approval from the Food and Drug Administration for its cholesterol-measuring device, the company said. The FDA move could be a boon for the private company, which had $8 million in sales last […]